The CE mark has been awarded to a new-generation of Abbott Vascular’s everolimus-eluting, metallic stent Xience. The Xience Sierra, according to a press release, has a new stent design, a new delivery system, and unique sizes.
The press release reports that these features – including a thinner profile, increased flexibility, longer lengths, and small-diameters – allow operators to use Xience Sierra for complicated cases.
Charles Simonton, chief medical officer of Abbott’s vascular business, comments: “Xience Sierra can help cardiologists be even more precise when implanting the stent, which is important for efficacy and safety. Its design, range of sizes, and increased flexibility mean doctors don’t have to use as much force when they implant a Xience Sierra stent compared to other stents.”
“Doctors tell us they need better tools to treat increasingly challenging cases, which involve multiple, or totally blocked arteries and complications such as diabetes. We designed Xience Sierra with the goal of helping more people with coronary artery disease regain their health and return to their daily lives as quickly as possible,” says Chuck Brynelsen, senior vice president of Abbott’s vascular business.